278 related articles for article (PubMed ID: 18262170)
1. Physiological and pharmacokinetic roles of H+/organic cation antiporters (MATE/SLC47A).
Terada T; Inui K
Biochem Pharmacol; 2008 May; 75(9):1689-96. PubMed ID: 18262170
[TBL] [Abstract][Full Text] [Related]
2. The MATE proteins as fundamental transporters of metabolic and xenobiotic organic cations.
Omote H; Hiasa M; Matsumoto T; Otsuka M; Moriyama Y
Trends Pharmacol Sci; 2006 Nov; 27(11):587-93. PubMed ID: 16996621
[TBL] [Abstract][Full Text] [Related]
3. Role of organic cation transporters in the renal handling of therapeutic agents and xenobiotics.
Wright SH
Toxicol Appl Pharmacol; 2005 May; 204(3):309-19. PubMed ID: 15845420
[TBL] [Abstract][Full Text] [Related]
4. Organic cation transporter OCT/SLC22A and H(+)/organic cation antiporter MATE/SLC47A are key molecules for nephrotoxicity of platinum agents.
Yonezawa A; Inui K
Biochem Pharmacol; 2011 Mar; 81(5):563-8. PubMed ID: 21144842
[TBL] [Abstract][Full Text] [Related]
5. Identification and functional characterization of a new human kidney-specific H+/organic cation antiporter, kidney-specific multidrug and toxin extrusion 2.
Masuda S; Terada T; Yonezawa A; Tanihara Y; Kishimoto K; Katsura T; Ogawa O; Inui K
J Am Soc Nephrol; 2006 Aug; 17(8):2127-35. PubMed ID: 16807400
[TBL] [Abstract][Full Text] [Related]
6. PDZK1 directly regulates the function of organic cation/carnitine transporter OCTN2.
Kato Y; Sai Y; Yoshida K; Watanabe C; Hirata T; Tsuji A
Mol Pharmacol; 2005 Mar; 67(3):734-43. PubMed ID: 15523054
[TBL] [Abstract][Full Text] [Related]
7. Mammalian MATE (SLC47A) transport proteins: impact on efflux of endogenous substrates and xenobiotics.
Damme K; Nies AT; Schaeffeler E; Schwab M
Drug Metab Rev; 2011 Nov; 43(4):499-523. PubMed ID: 21923552
[TBL] [Abstract][Full Text] [Related]
8. Organic cation transporters (OCTs, MATEs), in vitro and in vivo evidence for the importance in drug therapy.
Nies AT; Koepsell H; Damme K; Schwab M
Handb Exp Pharmacol; 2011; (201):105-67. PubMed ID: 21103969
[TBL] [Abstract][Full Text] [Related]
9. A novel variant of mouse MATE-1 H+/organic cation antiporter with a long hydrophobic tail.
Kobara A; Hiasa M; Matsumoto T; Otsuka M; Omote H; Moriyama Y
Arch Biochem Biophys; 2008 Jan; 469(2):195-9. PubMed ID: 17983590
[TBL] [Abstract][Full Text] [Related]
10. Multidrug and toxin extrusion family SLC47: physiological, pharmacokinetic and toxicokinetic importance of MATE1 and MATE2-K.
Motohashi H; Inui K
Mol Aspects Med; 2013; 34(2-3):661-8. PubMed ID: 23506899
[TBL] [Abstract][Full Text] [Related]
11. Altered pharmacokinetics of cationic drugs caused by down-regulation of renal rat organic cation transporter 2 (Slc22a2) and rat multidrug and toxin extrusion 1 (Slc47a1) in ischemia/reperfusion-induced acute kidney injury.
Matsuzaki T; Morisaki T; Sugimoto W; Yokoo K; Sato D; Nonoguchi H; Tomita K; Terada T; Inui K; Hamada A; Saito H
Drug Metab Dispos; 2008 Apr; 36(4):649-54. PubMed ID: 18180268
[TBL] [Abstract][Full Text] [Related]
12. Molecular and cellular physiology of renal organic cation and anion transport.
Wright SH; Dantzler WH
Physiol Rev; 2004 Jul; 84(3):987-1049. PubMed ID: 15269342
[TBL] [Abstract][Full Text] [Related]
13. Organic cation transporter OCTs (SLC22) and MATEs (SLC47) in the human kidney.
Motohashi H; Inui K
AAPS J; 2013 Apr; 15(2):581-8. PubMed ID: 23435786
[TBL] [Abstract][Full Text] [Related]
14. Molecular identification and functional characterization of rat multidrug and toxin extrusion type transporter 1 as an organic cation/H+ antiporter in the kidney.
Ohta KY; Inoue K; Hayashi Y; Yuasa H
Drug Metab Dispos; 2006 Nov; 34(11):1868-74. PubMed ID: 16928787
[TBL] [Abstract][Full Text] [Related]
15. Importance of the multidrug and toxin extrusion MATE/SLC47A family to pharmacokinetics, pharmacodynamics/toxicodynamics and pharmacogenomics.
Yonezawa A; Inui K
Br J Pharmacol; 2011 Dec; 164(7):1817-25. PubMed ID: 21457222
[TBL] [Abstract][Full Text] [Related]
16. Substrate specificity of organic cation/H+ exchange in avian renal brush-border membranes.
Villalobos AR; Braun EJ
J Pharmacol Exp Ther; 1998 Dec; 287(3):944-51. PubMed ID: 9864277
[TBL] [Abstract][Full Text] [Related]
17. Oppositely directed H+ gradient functions as a driving force of rat H+/organic cation antiporter MATE1.
Tsuda M; Terada T; Asaka J; Ueba M; Katsura T; Inui K
Am J Physiol Renal Physiol; 2007 Feb; 292(2):F593-8. PubMed ID: 17047166
[TBL] [Abstract][Full Text] [Related]
18. Possible involvement of organic anion and cation transporters in renal excretion of xanthine derivatives, 3-methylxanthine and enprofylline.
Nadai M; Kato M; Yoshizumi H; Kimura M; Kurono S; Abe F; Saito H; Hasegawa T
Life Sci; 2007 Sep; 81(15):1175-82. PubMed ID: 17897683
[TBL] [Abstract][Full Text] [Related]
19. Polyspecific organic cation transporters and their biomedical relevance in kidney.
Koepsell H
Curr Opin Nephrol Hypertens; 2013 Sep; 22(5):533-8. PubMed ID: 23852330
[TBL] [Abstract][Full Text] [Related]
20. Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications.
Koepsell H; Lips K; Volk C
Pharm Res; 2007 Jul; 24(7):1227-51. PubMed ID: 17473959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
